Dimensional Fund Advisors’s Intellia Therapeutics NTLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$17.5M Sell
1,866,309
-101,857
-5% -$955K ﹤0.01% 2035
2025
Q1
$14M Sell
1,968,166
-8,046
-0.4% -$57.2K ﹤0.01% 2108
2024
Q4
$23M Buy
1,976,212
+528,962
+37% +$6.17M 0.01% 1938
2024
Q3
$29.7M Buy
1,447,250
+122,689
+9% +$2.52M 0.01% 1800
2024
Q2
$29.6M Buy
1,324,561
+98,865
+8% +$2.21M 0.01% 1764
2024
Q1
$33.7M Buy
1,225,696
+54,867
+5% +$1.51M 0.01% 1710
2023
Q4
$35.7M Buy
1,170,829
+60,748
+5% +$1.85M 0.01% 1665
2023
Q3
$35.1M Buy
1,110,081
+83,840
+8% +$2.65M 0.01% 1587
2023
Q2
$41.9M Buy
1,026,241
+205,749
+25% +$8.39M 0.01% 1481
2023
Q1
$30.6M Sell
820,492
-99,584
-11% -$3.71M 0.01% 1680
2022
Q4
$32.1K Buy
920,076
+9,968
+1% +$348 0.01% 1611
2022
Q3
$50.9M Sell
910,108
-8,790
-1% -$492K 0.02% 1216
2022
Q2
$47.6M Sell
918,898
-26,849
-3% -$1.39M 0.02% 1323
2022
Q1
$68.7M Sell
945,747
-111,663
-11% -$8.11M 0.02% 1138
2021
Q4
$125M Sell
1,057,410
-83,348
-7% -$9.86M 0.04% 699
2021
Q3
$153M Buy
1,140,758
+437
+0% +$58.6K 0.05% 510
2021
Q2
$185M Buy
1,140,321
+151,568
+15% +$24.5M 0.06% 393
2021
Q1
$79.3M Buy
988,753
+4,280
+0.4% +$343K 0.03% 1036
2020
Q4
$53.6M Sell
984,473
-31,859
-3% -$1.73M 0.02% 1308
2020
Q3
$20.2M Sell
1,016,332
-52,194
-5% -$1.04M 0.01% 1844
2020
Q2
$22.5M Buy
1,068,526
+44,022
+4% +$925K 0.01% 1817
2020
Q1
$12.5M Buy
1,024,504
+15,187
+2% +$186K 0.01% 2003
2019
Q4
$14.8M Buy
1,009,317
+41,937
+4% +$615K 0.01% 2184
2019
Q3
$12.9M Buy
967,380
+97,150
+11% +$1.3M 0.01% 2231
2019
Q2
$14.2M Buy
870,230
+246,964
+40% +$4.04M 0.01% 2230
2019
Q1
$10.6M Buy
623,266
+363,007
+139% +$6.2M ﹤0.01% 2380
2018
Q4
$3.55M Buy
260,259
+217,071
+503% +$2.96M ﹤0.01% 2704
2018
Q3
$1.24M Buy
+43,188
New +$1.24M ﹤0.01% 3028
2018
Q1
Sell
-40,009
Closed -$769K 3354
2017
Q4
$769K Sell
40,009
-3,400
-8% -$65.4K ﹤0.01% 3035
2017
Q3
$1.08M Hold
43,409
﹤0.01% 2980
2017
Q2
$695K Buy
+43,409
New +$695K ﹤0.01% 3051